Menu

Arcturus Therapeutics Holdings Inc. ARCT

Full chart Compare
Set alert

Price alert · ARCT

All alert types
10.33 USD +0.97 (+10.36%)

Nov 6, 2026, 12:07 PM EST

10.07 Day range 10.80
5.50 52-week range 17.96
YTD
+68.52%
1 year
+24.61%

Revenue & Expenses

Other Income → Expenses: $9.17MOther Operating Income → Expenses: $19.14MExpenses → Selling, General & Admin: $46.08MExpenses → Research & Development: $112.21MGross Profit → Expenses: $64.20MRevenue → Gross Profit: $64.20MRevenue → Cost of Revenue: $3.02MNet Loss → Expenses: $65.78MOther Income$9.17MOther Operating Income$19.14MGross Profit$64.20MNet Loss$65.78MCost of Revenue$3.02MExpenses$158.29MSelling, General & Admin$46.08MResearch & Development$112.21MRevenue$67.22M

Latest period ending Dec 31, 2025 · select a line to chart its full history

ARCT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
82.03M152.31M166.80M206.00M12.36M
82.03M152.31M166.80M206.00M12.36M
-76.26M-95.67M-78.20M12.18M-202.85M
-65.78M-80.94M-29.73M9.35M-203.67M
-2.40-3.00-1.120.35-7.74
ARCT annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
230.91M292.03M347.00M391.88M370.49M
271.15M344.07M429.40M450.39M392.81M
57.16M103.09M150.89M180.07M164.60M
20.78M25.00M25.91M90.87M67.61M
213.99M240.98M278.51M270.31M228.21M
ARCT annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-74.27M-59.75M-18.10M31.99M-135.04M
-230.00K-648.00K-2.90M-7.73M-3.41M
13.38M5.42M-24.09M-2.86M48.02M
-230.00K-648.00K-2.90M-7.73M-3.41M
-61.12M-54.98M-45.09M21.41M-90.43M